Is ISRG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ISRG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ISRG (CHF472.72) is trading above our estimate of fair value (CHF316.85)
Significantly Below Fair Value: ISRG is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ISRG?
Key metric: As ISRG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for ISRG. This is calculated by dividing ISRG's market cap by their current
earnings.
What is ISRG's PE Ratio?
PE Ratio
83.3x
Earnings
US$2.24b
Market Cap
US$186.79b
ISRG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: ISRG is expensive based on its Price-To-Earnings Ratio (83.3x) compared to the European Medical Equipment industry average (29.6x).
Price to Earnings Ratio vs Fair Ratio
What is ISRG's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
ISRG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
83.3x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ISRG's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst ISRG forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
CHF 501.09
0%
14.3%
CHF 585.37
CHF 238.65
n/a
27
Dec ’25
CHF 478.75
CHF 475.81
-0.6%
12.8%
CHF 570.33
CHF 235.05
n/a
26
Nov ’25
CHF 442.58
CHF 458.82
+3.7%
12.0%
CHF 523.18
CHF 229.54
n/a
26
Oct ’25
CHF 406.94
CHF 411.65
+1.2%
12.2%
CHF 495.88
CHF 224.25
n/a
26
Sep ’25
CHF 406.54
CHF 406.04
-0.1%
12.4%
CHF 493.62
CHF 223.22
n/a
26
Aug ’25
n/a
CHF 415.93
0%
11.0%
CHF 465.25
CHF 234.84
n/a
25
Jul ’25
n/a
CHF 381.41
0%
11.2%
CHF 447.15
CHF 226.26
n/a
25
Jun ’25
n/a
CHF 382.67
0%
11.0%
CHF 451.73
CHF 228.57
n/a
25
May ’25
n/a
CHF 382.93
0%
10.5%
CHF 432.47
CHF 230.35
n/a
25
Apr ’25
n/a
CHF 373.46
0%
10.5%
CHF 428.37
CHF 228.17
n/a
25
Mar ’25
n/a
CHF 353.91
0%
12.1%
CHF 411.57
CHF 199.29
n/a
25
Feb ’25
n/a
CHF 347.47
0%
13.9%
CHF 409.81
CHF 198.43
n/a
25
Jan ’25
n/a
CHF 288.74
0%
13.2%
CHF 342.52
CHF 196.95
n/a
25
Dec ’24
n/a
CHF 288.65
0%
12.7%
CHF 353.49
CHF 203.26
CHF 478.75
25
Nov ’24
n/a
CHF 295.54
0%
12.8%
CHF 363.85
CHF 209.21
CHF 442.58
24
Oct ’24
n/a
CHF 311.26
0%
10.5%
CHF 344.02
CHF 197.81
CHF 406.94
23
Sep ’24
n/a
CHF 311.26
0%
10.5%
CHF 344.02
CHF 197.81
CHF 406.54
23
Aug ’24
n/a
CHF 311.26
0%
10.5%
CHF 344.02
CHF 197.81
n/a
23
Jul ’24
n/a
CHF 279.91
0%
10.5%
CHF 329.07
CHF 183.92
n/a
21
Jun ’24
n/a
CHF 279.15
0%
10.1%
CHF 330.60
CHF 184.78
n/a
21
May ’24
n/a
CHF 272.82
0%
9.6%
CHF 312.83
CHF 182.33
n/a
21
Apr ’24
n/a
CHF 249.46
0%
11.5%
CHF 298.64
CHF 187.46
n/a
21
Mar ’24
n/a
CHF 251.95
0%
12.3%
CHF 299.06
CHF 187.72
n/a
20
Feb ’24
n/a
CHF 251.95
0%
12.3%
CHF 299.06
CHF 187.72
n/a
20
Jan ’24
n/a
CHF 251.27
0%
14.7%
CHF 301.28
CHF 189.11
n/a
21
Dec ’23
n/a
CHF 248.34
0%
13.8%
CHF 310.06
CHF 194.62
n/a
20
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/12/22 13:53
End of Day Share Price
2024/12/09 00:00
Earnings
2024/09/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Intuitive Surgical, Inc. is covered by 59 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.